

See product citations (4)
QUICK LINKS
Sulfamethoxazole-d4 inhibits the synthesis of dihydrofolic acid by competing with para-aminobenzoic acid (PABA) for binding to dihydropteroate synthetase, an enzyme involved in the folic acid synthesis pathway. This disruption of folate metabolism ultimately leads to the inhibition of bacterial growth and proliferation. Sulfamethoxazole-d4 works with trimethoprim to target both the early and late stages of folic acid synthesis, resulting in a synergistic bactericidal effect. By interfering with the production of necessary metabolites, Sulfamethoxazole-d4 disrupts the cellular processes necessary for bacterial survival, making it an effective antibiotic against a wide range of Gram-positive and Gram-negative bacteria. This inhibition of folate synthesis is particularly for bacteria, as they are unable to take up preformed folic acid from their environment and must synthesize it de novo.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Sulfamethoxazole-d4, 5 mg | sc-220161 | 5 mg | $500.00 | |||
Sulfamethoxazole-d4, 25 mg | sc-220161A | 25 mg | $812.00 | |||
Sulfamethoxazole-d4, 50 mg | sc-220161B | 50 mg | $1200.00 | |||
Sulfamethoxazole-d4, 100 mg | sc-220161C | 100 mg | $2000.00 |